Arvinas Inc (ARVN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ARVN | BBOT | PRME | ||
| Company | Arvinas Inc | Bridgebio Oncology Therapeutics Inc | Prime Medicine Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 11.21 | 9.36 | 3.78 | ||
| High | 11.34 | 9.65 | 3.91 | ||
| Low | 10.97 | 9.23 | 3.76 | ||
| Latest | 11.00 | 9.35 | 3.81 | ||
| Change | unch | +0.13 | +0.14 | ||
| % Change | unch | +1.41% | +3.81% | ||
| Volume | 759,000 | 586,300 | 1,904,900 | ||
| 20-Day Average Volume | 914,275 | 319,310 | 2,324,900 | ||
| Previous Close | 11.00 | 9.22 | 3.67 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | No | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 10.84 | 8.92 | 3.52 | ||
| 20-Day Raw Stochastic | 49.69% | 80.98% | 88.51% | ||
| 20-Day Relative Strength | 45.58 | 48.87 | 53.36 | ||
| Weighted Alpha | +23.39 | -20.71 | +1.64 | ||
| Today's Opinion | 8% Sell | 88% Sell | 48% Sell | ||
| Previous Opinion | 8% Sell | 88% Sell | 72% Sell | ||
| Last Month's Opinion | 40% Buy | 88% Sell | 56% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.66% since 04/10/26 | +11.31% since 04/10/26 | +11.08% since 04/10/26 | ||
| Low | 10.56 on 04/13/26 | 8.50 on 04/14/26 | 3.36 on 04/13/26 | ||
| High | 11.34 on 04/17/26 | 9.65 on 04/17/26 | 3.91 on 04/17/26 | ||
| 1-Month | |||||
| %Chg | -8.41% since 03/17/26 | -1.37% since 03/17/26 | +2.70% since 03/17/26 | ||
| Low | 9.96 on 03/24/26 | 8.08 on 04/07/26 | 3.04 on 03/30/26 | ||
| High | 12.05 on 04/08/26 | 9.65 on 04/17/26 | 3.91 on 04/17/26 | ||
| 3-Month | |||||
| %Chg | -9.84% since 01/16/26 | -18.09% since 01/16/26 | -4.27% since 01/16/26 | ||
| Low | 9.96 on 03/24/26 | 8.08 on 04/07/26 | 3.04 on 03/30/26 | ||
| High | 14.51 on 03/10/26 | 13.99 on 01/27/26 | 4.77 on 03/02/26 | ||
| 6-Month | |||||
| %Chg | +15.55% since 10/17/25 | -16.14% since 10/17/25 | -30.09% since 10/17/25 | ||
| Low | 9.01 on 10/23/25 | 8.08 on 04/07/26 | 3.04 on 03/30/26 | ||
| High | 14.51 on 03/10/26 | 14.87 on 12/08/25 | 6.30 on 10/21/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 703,571 | 748,309 | 687,903 | ||
| Shares Outstanding, K | 63,961 | 80,033 | 180,552 | ||
| Annual Sales | 262,600,000 | 0 | 4,630,000 | ||
| Annual Net Income | -80,800,000 | -134,040,000 | -201,140,000 | ||
| Last Quarter Sales | 9,500,000 | 0 | 840,000 | ||
| Last Quarter Net Income | -67,400,000 | -38,800,000 | -46,080,000 | ||
| 60-Month Beta | 1.97 | 0.51 | 2.65 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -1.10 on 02/24/26 | -0.49 on 03/05/26 | -0.22 on 03/03/26 | ||
| Latest Earnings Date | 05/07/26 | 06/04/26 | 05/14/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | 09/10/19 | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||